Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-30 20:47:57 - browse：9135

A vial of Tofersen injection on the left of its box — The ALS drug tofersen is marketed as Qalsody in the U.S. Biogen

LONDON — Neurologists and patient advocates are up in arms over a policy decision by a U.K. health agency that they say will imperil access to an ALS treatment that’s available in the U.S. and on its way to approval in the European Union.

The medicine in question, Biogen’s tofersen, is designed to treat a rare genetic form of the neurodegenerative disease, accounting for some 2% of all ALS cases. And the issue is how the U.K.’s cost-effectiveness agency has said it would assess the costs and benefits of the therapy.

The agency, the National Institute for Health and Care Excellence, or NICE, has a special pathway for drugs for very rare diseases, which advocates and doctors argue is the route through which tofersen should be reviewed. But NICE has indicated it would review the drug through its standard process, saying it’s because ALS as a whole does not count as a “very rare” disease. That sets a higher bar to clear.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Women's World Cup brings attention to abuse in soccer

WSS

The dental labor crisis is a moment of opportunity

Blinken talks high

Doctors' information doesn't help them choose wisely when sick

The debate over Covid

Inflation cooled significantly in June, bringing price hikes close to normal levels

PhRMA lawsuit over Medicare drug price negotiation tossed

hotspot

Wikipedia

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Sickle cell gene therapy cures need to be accessible in Africa

United colonoscopy coverage change 'may cost lives,' doctors say

What should King Charles tell the public about his cancer?

Tori Bowie and the unacceptable rates of Black maternal death

France's anti

Malaria cases in Florida and Texas: Here’s what you need to know

To avoid data mishandling cases, universities eye AI and other tools

DIEP, the 'gold standard' of breast reconstruction, is under threat

China sends large group of warplanes, navy ships towards Taiwan in forceful display

focus

PhRMA lawsuit over Medicare drug price negotiation tossed

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Why did Pfizer dish out millions for a Super Bowl ad?

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

explore

leisure time

focus

focus